Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Advancing treatment efficacy: combined therapy of eribuli... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Advancing treatment efficacy: combined therapy of eribulin, anlotinib, and camrelizumab in advanced or metastatic retroperitoneal liposarcoma
0
Authors
Weiwei Jia
8 more
Weiwei Jia
•
Jianhui Wu
6 more
•
Chunyi Hao
Published
January 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Therapeutic Advances in Medical Oncology
Topics
Medicine
Cancer Oncology
Pathology
Internal Medicine
Surgery
Show all topics
DOI
10.1177/17588359241276968
License
CC-BY-NC
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Therapeutic Advances in Medical Oncology
Topics
Medicine
Cancer Oncology
Pathology
Internal Medicine
Surgery
Show all topics
DOI
10.1177/17588359241276968
License
CC-BY-NC
